Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
1.880
+0.060 (3.30%)
At close: Dec 20, 2024, 4:00 PM
1.970
+0.090 (4.79%)
After-hours: Dec 20, 2024, 5:56 PM EST
Sutro Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 155 | 261 | 464 | 689 | 988 | 254 | |
| Market Cap Growth | 35.03% | -43.69% | -32.55% | -30.31% | 288.95% | 23.24% | |
| Enterprise Value | -208 | -55 | 193 | 453 | 731 | 115 | |
| Last Close Price | 1.88 | 4.29 | 8.08 | 14.88 | 21.71 | 11.00 | |
| PS Ratio | 0.83 | 1.70 | 6.85 | 11.13 | 23.12 | 5.94 | |
| PB Ratio | 1.39 | 1.75 | 2.14 | 2.73 | 2.98 | 2.60 | |
| P/TBV Ratio | 2.55 | 1.75 | 2.14 | 2.73 | 2.98 | 2.60 | |
| P/OCF Ratio | - | - | 130.85 | - | - | - | |
| EV/Sales Ratio | - | - | 2.85 | 7.32 | 17.11 | 2.69 | |
| Debt / Equity Ratio | 0.22 | 0.22 | 0.23 | 0.23 | 0.07 | 0.10 | |
| Asset Turnover | 0.36 | 0.35 | 0.18 | 0.17 | 0.16 | 0.23 | |
| Quick Ratio | 3.01 | 4.39 | 5.13 | 5.04 | 12.63 | 3.77 | |
| Current Ratio | 3.09 | 4.50 | 5.31 | 5.24 | 12.78 | 3.90 | |
| Return on Equity (ROE) | -110.89% | -58.25% | -50.77% | -36.11% | -14.95% | -48.62% | |
| Return on Assets (ROA) | -18.40% | -12.71% | -21.54% | -16.74% | -16.14% | -18.32% | |
| Return on Capital (ROIC) | -56.72% | -24.76% | -27.91% | -18.48% | -19.13% | -27.38% | |
| Earnings Yield | -79.96% | -40.84% | -25.67% | -15.33% | -3.25% | -21.95% | |
| FCF Yield | -70.44% | -44.33% | -0.93% | -14.09% | -7.58% | -26.97% | |
| Buyback Yield / Dilution | -20.70% | -18.57% | -10.02% | -41.58% | -41.88% | -298.66% | |
| Total Shareholder Return | -20.70% | -18.57% | -10.02% | -41.58% | -41.88% | -298.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.